2025. Development and Evaluation of a Chitosan-based Topical Gel of Dinalbuphine sebacate for Targeted Management of Rheumatoid Arthritis. Asian Journal of Pharmaceutics (AJP). 19, 2 (Jul. 2025). DOI:https://doi.org/10.22377/ajp.v19i2.6471.